Detalles de la búsqueda
1.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 331(21): 1814-1823, 2024 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722621
2.
Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with metastatic Merkel cell carcinoma.
Health Qual Life Outcomes
; 18(1): 145, 2020 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32430019
3.
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.
Cancer Immunol Immunother
; 68(4): 609-618, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30721341
4.
Nonprogression with avelumab treatment associated with gains in quality of life in metastatic Merkel cell carcinoma.
Future Oncol
; 14(3): 255-266, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29219612
5.
Experiences of participants in a collaborative to develop performance measures for hospice care.
Jt Comm J Qual Patient Saf
; 37(1): 38-44, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21306064
6.
Evaluation of the potential for QTc prolongation with avelumab.
Cancer Chemother Pharmacol
; 84(5): 1017-1026, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31478078
7.
Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma.
Clin J Oncol Nurs
; 23(1): E1-E9, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30682006
8.
Comparative effectiveness of avelumab versus chemotherapy in Merkel cell carcinoma: innovative use of patient insights.
J Comp Eff Res
; 7(9): 881-890, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30107762
9.
How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical trial.
Orphanet J Rare Dis
; 13(1): 95, 2018 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29914528
10.
Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.
JAMA Oncol
; 4(9): e180077, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566106
11.
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
J Immunother Cancer
; 6(1): 7, 2018 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29347993
12.
Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization".
AAPS J
; 16(4): 698-704, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24821054
13.
Testing a standardized symptom assessment tool: experiences from the NAHC QAPI Collaborative.
Caring
; 27(11): 14-8, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19068871
14.
Benefits and challenges in use of a standardized symptom assessment instrument in hospice.
J Palliat Med
; 13(2): 155-9, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19827961
Resultados
1 -
14
de 14
1
Próxima >
>>